Eikon Therapeutics, Inc (EIKN) Stock Price Today & Analysis
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
About Eikon Therapeutics, Inc
The company is a late-stage clinical biopharmaceutical organization focused on building a global, fully integrated platform to develop innovative medicines that address serious unmet medical needs. It is led by internationally recognized drug development leaders Dr. Roger M. Perlmutter, M.D., Ph.D., and Dr. Roy Baynes, M.D., Ph.D. The company’s vision is to become a generational leader by intentionally integrating traditional biological research with advanced engineering capabilities to accelerate the development of higher-quality medicines. Its initial therapeutic focus is oncology, with a pipeline of drug candidates targeting areas of significant unmet need across large patient populations.
FAQ
- Download the Gotrade app from the App Store or Google Play.
- Create an account and complete KYC.
- Make a deposit.
- Search for the code "EIKN", then tap "Trade".
- Tap the "Buy" button.
- Enter the amount you want to buy. You have two options:
- Buy EIKN by number of shares.
- Buy fractional shares in dollars, starting from $1.
- Swipe up to confirm your order—done!
- Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
- Review revenue and earnings growth.
- Check margins and cash flow.
- Evaluate business outlook and the company's position within its industry.





